AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 48 filers reported holding AGILE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $158,000 | -53.8% | 757,888 | +8.0% | 0.00% | – |
| Q4 2021 | $342,000 | -49.3% | 701,751 | 0.0% | 0.00% | – |
| Q3 2021 | $674,000 | -29.9% | 701,751 | -3.0% | 0.00% | – |
| Q2 2021 | $962,000 | -62.6% | 723,700 | -41.5% | 0.00% | – |
| Q1 2021 | $2,573,000 | -18.7% | 1,237,241 | +12.2% | 0.00% | -100.0% |
| Q4 2020 | $3,163,000 | +0.5% | 1,102,242 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $3,146,000 | +12.0% | 1,035,166 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $2,809,000 | +156.5% | 1,010,463 | +71.5% | 0.00% | – |
| Q1 2020 | $1,095,000 | -48.3% | 589,092 | -30.5% | 0.00% | – |
| Q4 2019 | $2,120,000 | +536.6% | 848,112 | +201.6% | 0.00% | – |
| Q3 2019 | $333,000 | -18.8% | 281,210 | 0.0% | 0.00% | – |
| Q2 2019 | $410,000 | -3.3% | 281,210 | 0.0% | 0.00% | – |
| Q1 2019 | $424,000 | +60.6% | 281,210 | -39.0% | 0.00% | – |
| Q4 2018 | $264,000 | +288.2% | 460,992 | +148.0% | 0.00% | – |
| Q3 2018 | $68,000 | -25.3% | 185,857 | 0.0% | 0.00% | – |
| Q2 2018 | $91,000 | -79.3% | 185,857 | +8.5% | 0.00% | – |
| Q1 2018 | $440,000 | -4.3% | 171,318 | 0.0% | 0.00% | – |
| Q4 2017 | $460,000 | -39.8% | 171,318 | 0.0% | 0.00% | – |
| Q3 2017 | $764,000 | +19.0% | 171,318 | 0.0% | 0.00% | – |
| Q2 2017 | $642,000 | -0.3% | 171,318 | -14.8% | 0.00% | – |
| Q1 2017 | $644,000 | -3.3% | 201,152 | +72.0% | 0.00% | – |
| Q4 2016 | $666,000 | -16.3% | 116,940 | +2.5% | 0.00% | – |
| Q3 2016 | $796,000 | +18.6% | 114,079 | +29.3% | 0.00% | – |
| Q2 2016 | $671,000 | +27.8% | 88,246 | +4.2% | 0.00% | – |
| Q1 2016 | $525,000 | -8.4% | 84,671 | +44.0% | 0.00% | – |
| Q4 2015 | $573,000 | +48.1% | 58,803 | +2.2% | 0.00% | – |
| Q3 2015 | $387,000 | -14.6% | 57,556 | +9.0% | 0.00% | – |
| Q2 2015 | $453,000 | +19.8% | 52,794 | +29.4% | 0.00% | – |
| Q1 2015 | $378,000 | +118.5% | 40,796 | +44.6% | 0.00% | – |
| Q4 2014 | $173,000 | -15.6% | 28,214 | 0.0% | 0.00% | – |
| Q3 2014 | $205,000 | – | 28,214 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |